Revised & updated:
Greater than 5 years. This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.
The purpose of this Position Statement is to provide information and recommendations on genetic testing for women diagnosed with invasive epithelial ovarian cancer, based on available evidence and on consensus. The scope of this Position Statement encompasses genetic testing for heritable, or germline, gene mutations, with a focus on genetic testing of BRCA1 and BRCA2. The intended audiences are health professionals, medical colleges, consumers, media and policy makers.